ICU
SeaStar Medical Holding Corp
Company overview
- Market capitalization
- $14.98M
- Employees
- 17
- Latest publication
- 2026-09-29
About SeaStar Medical Holding Corp
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 615,000USD | 495,000USD | 420,000USD | 183,000USD | 338,000USD | 293,000USD | 67,000USD | 68,000USD |
| Cost Of Revenue | 54,000USD | 46,000USD | 12,000USD | 14,000USD | 27,000USD | 0USD | 0USD | 0USD |
| Gross Profit | 561,000USD | 449,000USD | 408,000USD | 169,000USD | 311,000USD | 293,000USD | 67,000USD | 68,000USD |
| Research Development | 2,520,000USD | 2,344,000USD | 2,200,000USD | 1,850,000USD | 1,037,000USD | 2,431,000USD | 2,738,000USD | 2,336,000USD |
| Selling General Administrative | 1,832,000USD | 1,708,000USD | 1,224,000USD | 1,898,000USD | 1,030,000USD | 1,684,000USD | 2,096,000USD | 2,188,000USD |
| General And Administrative Expenses | 1,832,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 4,352,000USD | 4,051,999USD | 3,424,000USD | 3,748,000USD | 2,067,000USD | 4,115,000USD | 4,834,000USD | 4,524,000USD |
| Operating Income | -3,791,000USD | -3,603,000USD | -3,016,000USD | -3,579,000USD | -1,756,000USD | -3,822,000USD | -4,767,000USD | -4,456,000USD |
| Total Other Income Expense Net | 61,000USD | 85,000USD | 112,000USD | 107,000USD | -246,000USD | 53,000USD | 348,000USD | -22,000USD |
| Interest Income | 69,000USD | 91,000USD | 125,000USD | 107,000USD | 45,000USD | 48,000USD | 19,000USD | 58,000USD |
| Interest Expense | 8,000USD | 6,000USD | 13,000USD | 0USD | 307,000USD | 11,000USD | 253,000USD | 272,000USD |
| Income Before Tax | -3,730,000USD | -3,518,000USD | -2,904,000USD | -3,472,000USD | -2,002,000USD | -3,769,000USD | -4,419,000USD | -4,478,000USD |
| Income Tax Expense | 0USD | 3,000USD | — | — | — | 3,000USD | — | — |
| Net Income | -3,730,000USD | -3,521,000USD | -2,904,000USD | -3,472,000USD | -2,002,000USD | -3,772,000USD | -4,419,000USD | -4,478,000USD |
| Net Interest Income | — | 85,000USD | 112,000USD | 107,000USD | -262,000USD | 37,000USD | 272,000USD | -214,000USD |
| Tax Provision | — | 3,000USD | 0USD | 0USD | 0USD | 3,000USD | 0USD | 0USD |
| Net Income From Continuing Ops | — | -3,521,000USD | -2,904,000USD | -3,472,000USD | -2,002,000USD | -3,772,000USD | -4,419,000USD | -4,478,000USD |
| Ebitda | — | -3,603,000USD | -2,891,000USD | -3,465,000USD | -1,993,000USD | -3,758,000USD | -4,672,000USD | -4,206,000USD |
| Ebit | — | — | — | -3,472,000USD | -1,756,000USD | -7,580,000USD | -4,419,000USD | -4,456,000USD |
| Depreciation And Amortization | — | — | — | 7,000USD | — | 3,822,000USD | -253,000USD | 250,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Revenue | 1,234,000USD | 135,000USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 53,000USD | 0USD | 0USD | — | — | — |
| Gross Profit | 1,181,000USD | 135,000USD | 0USD | — | — | — |
| Research Development | 7,518,000USD | 9,105,000USD | 5,973,000USD | 2,819,000USD | 2,766,000USD | 4,025,000USD |
| Selling General Administrative | 5,838,000USD | 8,872,000USD | 8,005,000USD | 6,600,000USD | 1,683,000USD | 2,363,000USD |
| Total Operating Expenses | 13,356,000USD | 17,977,000USD | 14,210,000USD | 11,609,000USD | 4,449,000USD | 6,453,000USD |
| Operating Income | -12,175,000USD | -17,842,000USD | -14,210,000USD | -11,609,000USD | -4,449,000USD | -6,453,000USD |
| Interest Income | 325,000USD | 101,000USD | 0USD | — | — | — |
| Interest Expense | 329,000USD | 244,000USD | 1,081,000USD | 630,000USD | 212,000USD | 3,308,000USD |
| Net Interest Income | -4,000USD | -143,000USD | -1,081,000USD | -630,000USD | -212,000USD | -3,308,000USD |
| Income Before Tax | -12,147,000USD | -24,827,000USD | -26,232,000USD | -23,012,000USD | -4,597,000USD | -3,267,000USD |
| Income Tax Expense | 3,000USD | 3,000USD | -14,010USD | 1,000USD | -1,000USD | 9,000USD |
| Tax Provision | 3,000USD | 3,000USD | 0USD | 1,000USD | -1,000USD | 9,000USD |
| Net Income | -12,150,000USD | -24,830,000USD | -26,232,000USD | -23,013,000USD | -4,596,000USD | -3,276,000USD |
| Net Income From Continuing Ops | -12,150,000USD | -24,830,000USD | -26,232,000USD | -23,013,000USD | -4,596,000USD | -3,276,000USD |
| Ebitda | -12,175,000USD | -24,583,000USD | -11,141,000USD | -11,609,000USD | -4,385,000USD | -5,236USD |
| Total Other Income Expense Net | 28,000USD | -6,985,000USD | -12,022,000USD | -10,773,000USD | -148,000USD | 3,186,000USD |
| Selling And Marketing Expenses | — | 32,000USD | 32,000USD | — | — | 65,000USD |
| Ebit | — | -42,425,000USD | -25,151,000USD | -11,609,000USD | -8,807,000USD | -12,822,000USD |
| Depreciation And Amortization | — | 17,842,000USD | 14,010,000USD | 11,609USD | 4,449,000USD | 6,453,000USD |
| Unclassified Operating Expenses | — | — | — | 2,190,000USD | — | — |
| Net Income Applicable To Common Shares | — | — | — | — | -4,596,000USD | -3,276,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 8,649,000USD | 11,263,000USD | 14,158,000USD | 15,530,000USD | 8,383,000USD | 7,597,000USD | 4,658,000USD | 4,586,000USD |
| Total Current Assets | 8,228,000USD | 10,764,000USD | 13,580,000USD | 14,874,000USD | 7,647,000USD | 6,784,000USD | 3,766,000USD | 3,616,000USD |
| Other Non Current Assets | 421,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 4,353,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 4,353,000USD | 3,948,000USD | 3,742,000USD | 4,066,000USD | 5,042,000USD | 7,032,000USD | 6,841,000USD | 6,638,000USD |
| Other Current Liabilities | 3,468,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 4,296,000USD | 7,315,000USD | 10,416,000USD | 11,464,000USD | 3,341,000USD | 565,000USD | -2,183,000USD | -2,052,000USD |
| Total Equity Including Noncontrolling Interest | 4,296,000USD | — | — | — | — | — | — | — |
| Net Receivables | 208,000USD | 179,000USD | 237,000USD | 221,000USD | 217,000USD | 110,000USD | 112,000USD | 68,000USD |
| Inventory | 77,000USD | 57,000USD | 66,000USD | 83,000USD | 77,000USD | 44,000USD | 0USD | — |
| Accounts Payable | 750,000USD | 719,000USD | 948,000USD | 2,018,000USD | 3,158,000USD | 3,397,000USD | 3,046,000USD | 3,687,000USD |
| Common Stock | 4,000USD | 4,000USD | 4,000USD | 3,000USD | 2,000USD | 2,000USD | 2,000USD | 1,000USD |
| Retained Earnings | -158,965,000USD | -155,235,000USD | -151,714,000USD | -148,810,000USD | -145,338,000USD | -143,336,000USD | -139,564,000USD | -135,145,000USD |
| Other Current Assets | — | 1,180,000USD | 1,297,000USD | 807,000USD | 1,051,000USD | 1,334,000USD | 1,835,000USD | 1,466,000USD |
| Total Liab | — | 3,948,000USD | 3,742,000USD | 4,066,000USD | 5,042,000USD | 7,032,000USD | 6,841,000USD | 6,638,000USD |
| Other Current Liab | — | 2,898,000USD | 2,269,000USD | 2,048,000USD | 1,884,000USD | 3,272,000USD | 3,221,000USD | 2,951,000USD |
| Capital Stock | — | 4,000USD | 4,000USD | 3,000USD | 2,000USD | 2,000USD | 2,000USD | 1,000USD |
| Cash | — | 9,348,000USD | 11,980,000USD | 13,763,000USD | 6,302,000USD | 5,296,000USD | 1,819,000USD | 2,082,000USD |
| Cash And Short Term Investments | — | 9,348,000USD | 11,980,000USD | 13,763,000USD | 6,302,000USD | 5,296,000USD | 1,819,000USD | 2,082,000USD |
| Net Debt | — | -9,017,000USD | -11,455,000USD | -13,763,000USD | -6,302,000USD | -4,933,000USD | -1,245,000USD | -2,082,000USD |
| Short Term Debt | — | 331,000USD | 525,000USD | — | — | 363,000USD | 574,000USD | — |
| Short Long Term Debt | — | 331,000USD | 525,000USD | — | — | 363,000USD | 574,000USD | — |
| Short Long Term Debt Total | — | 331,000USD | 525,000USD | — | — | 363,000USD | 574,000USD | — |
| Common Stock Shares Outstanding | — | 39,183,390shares | 20,730,870shares | 2,639,340shares | 1,750,570shares | 861,800shares | 492,000shares | 408,700shares |
| Non Current Assets Total | — | 499,000USD | 578,000USD | 656,000USD | 736,000USD | 813,000USD | 892,000USD | 970,000USD |
| Non Current Liabilities Total | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Non Currrent Assets Other | — | 499,000USD | 578,000USD | 656,000USD | 736,000USD | 813,000USD | 892,000USD | 970,000USD |
| Net Working Capital | — | 6,816,000USD | 9,838,000USD | 10,808,000USD | 2,605,000USD | -248,000USD | -3,075,000USD | -3,022,000USD |
| Unclassified Equity | — | 162,542,000USD | 162,122,000USD | 160,268,000USD | 148,675,000USD | 143,897,000USD | 137,377,000USD | 133,091,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Assets | 14,158,000USD | 4,658,000USD | 3,513,000USD | 3,038,000USD | 603,000USD | 2,909,000USD |
| Other Current Assets | 1,297,000USD | 1,835,000USD | 2,132,000USD | 1,472,000USD | 33,000USD | 45,000USD |
| Total Liab | 3,742,000USD | 6,841,000USD | 17,383,000USD | 23,800,000USD | 3,419,000USD | 74,492,000USD |
| Total Stockholder Equity | 10,416,000USD | -2,183,000USD | -13,870,000USD | -20,762,000USD | -2,816,000USD | -71,583,000USD |
| Other Current Liab | 2,269,000USD | 3,221,000USD | 3,930,000USD | 13,043,000USD | 657,000USD | 678,000USD |
| Common Stock | 4,000USD | 2,000USD | 5,000USD | 1,000USD | 1,000USD | 215USD |
| Capital Stock | 4,000USD | 2,000USD | 5,000USD | 1,000USD | 1,000USD | 0USD |
| Retained Earnings | -151,714,000USD | -139,564,000USD | -114,734,000USD | -88,502,000USD | -76,312,000USD | -71,716,000USD |
| Cash | 11,980,000USD | 1,819,000USD | 176,000USD | 47,000USD | 510,000USD | 2,807,000USD |
| Cash And Short Term Investments | 11,980,000USD | 1,819,000USD | 176,000USD | 47,000USD | 510,000USD | 2,807,000USD |
| Total Current Assets | 13,580,000USD | 3,766,000USD | 2,308,000USD | 1,519,000USD | 601,000USD | 2,907,000USD |
| Total Current Liabilities | 3,742,000USD | 6,841,000USD | 13,046,000USD | 16,148,000USD | 3,120,000USD | 1,080,000USD |
| Net Debt | -11,455,000USD | -1,245,000USD | 8,905,000USD | 8,783,000USD | 2,112,000USD | -2,724,000USD |
| Short Term Debt | 525,000USD | 574,000USD | 4,744,000USD | 1,178,000USD | 2,378,000USD | 20,000USD |
| Short Long Term Debt | 525,000USD | 574,000USD | 4,744,000USD | 1,178,000USD | 2,378,000USD | 20,000USD |
| Short Long Term Debt Total | 525,000USD | 574,000USD | 9,081,000USD | 8,830,000USD | 2,622,000USD | 83,000USD |
| Net Receivables | 237,000USD | 112,000USD | 0USD | 12,000USD | 58,000USD | 44,955USD |
| Inventory | 66,000USD | 0USD | — | — | 0USD | 55,000USD |
| Accounts Payable | 948,000USD | 3,046,000USD | 4,372,000USD | 1,927,000USD | 85,000USD | 382,000USD |
| Common Stock Shares Outstanding | 20,730,870shares | 374,400shares | 86,681shares | 52,134shares | 52,164shares | 52,164shares |
| Non Current Assets Total | 578,000USD | 892,000USD | 1,205,000USD | 1,519,000USD | 2,000USD | 2,000USD |
| Non Current Liabilities Total | 0USD | 4,337,000USD | 4,337,000USD | 7,652,000USD | 299,000USD | 73,412,000USD |
| Non Currrent Assets Other | 578,000USD | 892,000USD | 1,205,000USD | 1,519,000USD | 2,000USD | 2,000USD |
| Net Working Capital | 9,838,000USD | -3,075,000USD | -10,738,000USD | -2,314,000USD | -2,519,000USD | 1,827,000USD |
| Unclassified Equity | 162,122,000USD | 137,377,000USD | 100,854,000USD | 67,738,000USD | 73,494,000USD | — |
| Unclassified Non Current Liabilities | — | 4,337,000USD | — | — | — | 73,349,000USD |
| Current Deferred Revenue | — | — | -5,042,000USD | — | 186,000USD | — |
| Long Term Debt | — | — | 4,337,000USD | 7,652,000USD | 244,000USD | 63,000USD |
| Unclassified Current Liabilities | — | — | -4,744,000USD | -1,178,000USD | -2,564,000USD | — |
| Accumulated Other Comprehensive Income | — | — | — | 0USD | — | -73,564USD |
| Other Liab | — | — | — | — | 55,000USD | — |
| Other Assets | — | — | — | — | 2,000USD | 2,000USD |
| Net Tangible Assets | — | — | — | — | -76,165,000USD | -71,583,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -3,521,000USD | -2,904,000USD | -3,472,000USD | -2,002,000USD | -3,772,000USD | -4,419,000USD | -4,478,000USD | -3,236,000USD |
| Depreciation | 6,000USD | — | 7,000USD | 7,000USD | 11,000USD | -27,000USD | 75,000USD | 30,000USD |
| Stock Based Compensation | 91,000USD | 70,000USD | 290,000USD | 97,000USD | 167,000USD | 212,000USD | 200,000USD | 41,000USD |
| Other Non Cash Items | 97,000USD | -825,000USD | 290,000USD | 289,000USD | -5,000USD | -76,000USD | -148,000USD | -1,463,000USD |
| Change To Account Receivables | 58,000USD | -16,000USD | -4,000USD | -107,000USD | 2,000USD | -44,000USD | -68,000USD | 0USD |
| Change To Inventory | 9,000USD | 17,000USD | -6,000USD | -33,000USD | -44,000USD | — | 0USD | 0USD |
| Change In Working Capital | 663,000USD | -1,260,000USD | -662,000USD | -1,391,000USD | 956,000USD | -410,000USD | -576,000USD | 1,834,000USD |
| Total Cash From Operating Activities | -2,761,000USD | -4,094,000USD | -3,844,000USD | -3,007,000USD | -2,654,000USD | -4,693,000USD | -5,002,000USD | -2,824,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -2,761,000USD | -4,094,000USD | -3,844,000USD | -3,007,000USD | -2,654,000USD | -4,693,000USD | -5,002,000USD | -2,824,000USD |
| Net Borrowings | -200,000USD | 525,000USD | 0USD | -370,000USD | -222,000USD | 571,000USD | -3,185,000USD | — |
| Total Cash From Financing Activities | 129,000USD | 2,311,000USD | 11,305,000USD | 4,013,000USD | 6,131,000USD | 4,430,000USD | 5,905,000USD | -1,016,000USD |
| Issuance Of Capital Stock | 329,000USD | 1,789,000USD | 9,183,000USD | 3,588,000USD | 1,566,000USD | 3,859,000USD | 9,090,000USD | -51,000USD |
| Change In Cash | -2,632,000USD | -1,783,000USD | 7,461,000USD | 1,006,000USD | 3,477,000USD | -263,000USD | 902,999USD | -3,840,000USD |
| Begin Period Cash Flow | 11,980,000USD | 13,763,000USD | 6,302,000USD | 5,296,000USD | 1,819,000USD | 2,082,000USD | 1,179,000USD | 5,019,000USD |
| End Period Cash Flow | 9,348,000USD | 11,980,000USD | 13,763,000USD | 6,302,000USD | 5,296,000USD | 1,819,000USD | 2,081,999USD | 1,179,000USD |
| Other Cashflows From Financing Activities | 129,000USD | 2,311,000USD | 11,305,000USD | 795,000USD | 4,787,000USD | — | 9,090,000USD | -3,000USD |
| Unclassified Financing Cash Flow | — | -2,314,000USD | -9,183,000USD | — | — | — | -9,090,000USD | — |
| Sale Purchase Of Stock | — | — | — | — | — | — | — | -51,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Net Income | -12,150,000USD | -24,830,000USD | -26,232,000USD | -12,190,000USD | -4,596,000USD | -3,276,000USD |
| Depreciation | 18,000USD | — | — | — | — | — |
| Stock Based Compensation | 624,000USD | 887,000USD | 1,930,000USD | 1,311,000USD | 14,000USD | 16USD |
| Other Non Cash Items | 266,000USD | 6,944,000USD | 11,140,000USD | 533,000USD | 148,000USD | -3,186,000USD |
| Change To Account Receivables | -125,000USD | -112,000USD | 12,000USD | 4,000USD | — | — |
| Change To Inventory | -66,000USD | 0USD | — | -4,000USD | 55,000USD | 137,000USD |
| Change In Working Capital | -2,357,000USD | 992,000USD | 2,877,000USD | 2,552,000USD | -680,000USD | 890,000USD |
| Total Cash From Operating Activities | -13,599,000USD | -16,007,000USD | -10,285,000USD | -7,794,000USD | -5,114,000USD | -5,572,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | 0USD | -5USD |
| Free Cash Flow | -13,599,000USD | -16,007,000USD | -10,285,000USD | -7,794,000USD | -5,114,000USD | -5,572,000USD |
| Net Borrowings | -67,000USD | -4,410,000USD | 3,530,000USD | 3,481,000USD | 2,817,000USD | -133,000USD |
| Total Cash From Financing Activities | 23,760,000USD | 17,650,000USD | 10,414,000USD | 7,331,000USD | 2,817,000USD | 4,892,000USD |
| Issuance Of Capital Stock | 16,126,000USD | 17,441,000USD | 6,612,000USD | 10,001,000USD | 0USD | 5,025,000USD |
| Change In Cash | 10,161,000USD | 1,643,000USD | 129,000USD | -463,000USD | 471,612USD | -680,000USD |
| Begin Period Cash Flow | 1,819,000USD | 176,000USD | 47,000USD | 510,000USD | 38,388USD | 3,487,000USD |
| End Period Cash Flow | 11,980,000USD | 1,819,000USD | 176,000USD | 47,000USD | 510,000USD | 2,807,000USD |
| Other Cashflows From Financing Activities | 23,760,000USD | 4,619,000USD | 272,000USD | -6,151,000USD | -105,570,000USD | 5,025,000USD |
| Unclassified Financing Cash Flow | -16,059,000USD | — | — | — | 105,570,000USD | -5,025,000USD |
| Change To Liabilities | — | — | — | — | -297,000USD | 225,000USD |
| Total Cashflows From Investing Activities | — | — | — | — | -105,570,000USD | — |
| Other Cashflows From Investing Activities | — | — | — | — | 105,570,000USD | — |
| Unclassified Investing Cash Flow | — | — | — | — | -211,140,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.